|
1
|
Vinceti M, Dennert G, Crespi CM, Zwahlen
M, Brinkman M, Zeegers MP, Horneber M, D'Amico R and Del Giovane C:
Selenium for preventing cancer. Cochrane Database Syst Rev.
3:CD0051952014.
|
|
2
|
Lance P, Alberts DS, Thompson PA, Fales L,
Wang F, Jose San J, Jacobs ET, Goodman PJ, Darke AK, Yee M, et al:
Colorectal adenomas in participants of the SELECT randomized trial
of selenium and vitamin E for prostate cancer prevention. Cancer
Prev Res (Phila). 10:45–54. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Thompson PA, Ashbeck EL, Roe DJ, Fales L,
Buckmeier J, Wang F, Bhattacharyya A, Hsu CH, Chow HH, Ahnen DJ, et
al: Selenium supplementation for prevention of colorectal adenomas
and risk of associated type 2 diabetes. J Natl Cancer Inst.
108:pii: djw152. 2016. View Article : Google Scholar
|
|
4
|
Institute of Medicine Food and Nutrition
Board: Dietary references intakes for vitamin C, vitamin E,
selenium, and carotenoids. National Academy Press; Washington, DC:
2000
|
|
5
|
Vinceti M, Crespi CM, Bonvicini F,
Malagoli C, Ferrante M, Marmiroli S and Stranges S: The need for a
reassessment of the safe upper limit of selenium in drinking water.
Sci Total Environ. 443:633–642. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rothman KJ, Greenland S and Lash TL:
Modern Epidemiology. Lippincott Williams & Wilkins;
Philadelphia: 2012, View Article : Google Scholar
|
|
7
|
Michalke B, Halbach S and Nischwitz V: JEM
spotlight: Metal speciation related to neurotoxicity in humans. J
Environ Monit. 11:939–954. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gammelgaard B, Jackson MI and Gabel-Jensen
C: Surveying selenium speciation from soil to cell--forms and
transformations. Anal Bioanal Chem. 399:1743–1763. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Weekley CM and Harris HH: Which form is
that? The importance of selenium speciation and metabolism in the
prevention and treatment of disease. Chem Soc Rev. 42:8870–8894.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Vinceti M, Solovyev N, Mandrioli J, Crespi
CM, Bonvicini F, Arcolin E, Georgoulopoulou E and Michalke B:
Cerebrospinal fluid of newly diagnosed amyotrophic lateral
sclerosis patients exhibits abnormal levels of selenium species
including elevated selenite. Neurotoxicology. 38:25–32. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Vinceti M, Grill P, Malagoli C, Filippini
T, Storani S, Malavolti M and Michalke B: Selenium speciation in
human serum and its implications for epidemiologic research: A
cross-sectional study. J Trace Elem Med Biol. 31:1–10. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Vinceti M, Wei ET, Malagoli C, Bergomi M
and Vivoli G: Adverse health effects of selenium in humans. Rev
Environ Health. 16:233–251. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Vinceti M, Mandrioli J, Borella P,
Michalke B, Tsatsakis A and Finkelstein Y: Selenium neurotoxicity
in humans: Bridging laboratory and epidemiologic studies. Toxicol
Lett. 230:295–303. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Vinceti M, Crespi CM, Malagoli C, Del
Giovane C and Krogh V: Friend or foe? The current epidemiologic
evidence on selenium and human cancer risk. J Environ Sci Health C
Environ Carcinog Ecotoxicol Rev. 31:305–341. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Vinceti M, Burlingame B, Fillippini T,
Naska A, Bargellini A and Borella P: The epidemiology of selenium
and human healthSelenium: Its Molecular Biology and Role in Human
Health. Hatfield D, Schweizer U and Gladyshev VN: 4th. Springer
Science Business Media; New York: pp. 365–376. 2016, View Article : Google Scholar
|
|
16
|
Joint FAO/WHO Expert Consultation on Human
Vitamin and Mineral Requirements: Vitamin and mineral requirements
in human nutrition. 2nd. World Health Organization and Food and
Agriculture Organization of the United Nations; Geneva: 2004
|
|
17
|
Keshan Disease Research Group of the
Chinese Academy of Medical Sciences: Epidemiologic studies on the
etiologic relationship of selenium and Keshan disease. Chin Med J
(Engl). 92:477–482. 1979.PubMed/NCBI
|
|
18
|
Keshan Disease Research Group of the
Chinese Academy of Medical Sciences: Observations on effect of
sodium selenite in prevention of Keshan disease. Chin Med J (Engl).
92:471–476. 1979.PubMed/NCBI
|
|
19
|
Wang T and Li Q: Interpretation of
selenium deficiency and Keshan disease with causal inference of
modern epidemiologyThe 5th International Selenium Seminar.
Organizing Committee of the International Selenium Seminar; Moscow:
pp. 34–35. 2015
|
|
20
|
Lei C, Niu X, Ma X and Wei J: Is selenium
deficiency really the cause of Keshan disease? Environ Geochem
Health. 33:183–188. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Winther KH, Bonnema SJ, Cold F, Debrabant
B, Nybo M, Cold S and Hegedüs L: Does selenium supplementation
affect thyroid function? Results from a randomized, controlled,
double-blinded trial in a Danish population. Eur J Endocrinol.
172:657–667. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Stranges S, Marshall JR, Natarajan R,
Donahue RP, Trevisan M, Combs GF, Cappuccio FP, Ceriello A and Reid
ME: Effects of long-term selenium supplementation on the incidence
of type 2 diabetes: A randomized trial. Ann Intern Med.
147:217–223. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lippman SM, Klein EA, Goodman PJ, Lucia
MS, Thompson IM, Ford LG, Parnes HL, Minasian LM, Gaziano JM,
Hartline JA, et al: Effect of selenium and vitamin E on risk of
prostate cancer and other cancers: The Selenium and Vitamin E
Cancer Prevention Trial (SELECT). JAMA. 301:39–51. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Vinceti M, Rovesti S, Gabrielli C,
Marchesi C, Bergomi M, Martini M and Vivoli G: Cancer mortality in
a residential cohort exposed to environmental selenium through
drinking water. J Clin Epidemiol. 48:1091–1097. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Vinceti M, Rothman KJ, Bergomi M, Borciani
N, Serra L and Vivoli G: Excess melanoma incidence in a cohort
exposed to high levels of environmental selenium. Cancer Epidemiol
Biomarkers Prev. 7:853–856. 1998.PubMed/NCBI
|
|
26
|
Vinceti M, Ballotari P, Steinmaus C,
Malagoli C, Luberto F, Malavolti M and Rossi Giorgi P: Long-term
mortality patterns in a residential cohort exposed to inorganic
selenium in drinking water. Environ Res. 150:348–356. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Saint-Amour D, Roy MS, Bastien C, Ayotte
P, Dewailly E, Després C, Gingras S and Muckle G: Alterations of
visual evoked potentials in preschool Inuit children exposed to
methylmercury and polychlorinated biphenyls from a marine diet.
Neurotoxicology. 27:567–578. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Vinceti M, Bonvicini F, Rothman KJ,
Vescovi L and Wang F: The relation between amyotrophic lateral
sclerosis and inorganic selenium in drinking water: A
population-based case-control study. Environ Health. 9:772010.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Vinceti M and Rothman KJ: More results but
no clear conclusion on selenium and cancer. Am J Clin Nutr.
104:245–246. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hughes DJ, Duarte-Salles T, Hybsier S,
Trichopoulou A, Stepien M, Aleksandrova K, Overvad K, Tjønneland A,
Olsen A, Affret A, et al: Prediagnostic selenium status and
hepatobiliary cancer risk in the European Prospective Investigation
into Cancer and Nutrition cohort. Am J Clin Nutr. 104:406–414.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ma X, Yang Y, Li HL, Zheng W, Gao J, Zhang
W, Yang G, Shu XO and Xiang YB: Dietary trace element intake and
liver cancer risk: Results from two population-based cohorts in
China. Int J Cancer. 140:1050–1059. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Knekt P, Marniemi J, Teppo L, Heliövaara M
and Aromaa A: Is low selenium status a risk factor for lung cancer?
Am J Epidemiol. 148:975–982. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
van den Brandt PA, Goldbohm RA, van't Veer
P, Bode P, Dorant E, Hermus RJ and Sturmans F: A prospective cohort
study on selenium status and the risk of lung cancer. Cancer Res.
53:4860–4865. 1993.PubMed/NCBI
|
|
34
|
Suadicani P, Hein HO and Gyntelberg F:
Serum selenium level and risk of lung cancer mortality: A 16-year
follow-up of the Copenhagen Male Study. Eur Respir J. 39:1443–1448.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Menkes MS, Comstock GW, Vuilleumier JP,
Helsing KJ, Rider AA and Brookmeyer R: Serum beta-carotene,
vitamins A and E, selenium, and the risk of lung cancer. N Engl J
Med. 315:1250–1254. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
van Noord PA, Maas MJ, van der Tweel I and
Collette C: Selenium and the risk of postmenopausal breast cancer
in the DOM cohort. Breast Cancer Res Treat. 25:11–19. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
van den Brandt PA, Goldbohm RA, van't Veer
P, Bode P, Dorant E, Hermus RJ and Sturmans F: Toenail selenium
levels and the risk of breast cancer. Am J Epidemiol. 140:20–26.
1994. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Garland M, Morris JS, Stampfer MJ, Colditz
GA, Spate VL, Baskett CK, Rosner B, Speizer FE, Willett WC and
Hunter DJ: Prospective study of toenail selenium levels and cancer
among women. J Natl Cancer Inst. 87:497–505. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Clark LC, Combs GFJ Jr, Turnbull BW, Slate
EH, Chalker DK, Chow J, Davis LS, Glover RA, Graham GF, Gross EG,
et al: Nutritional Prevention of Cancer Study Group: Effects of
selenium supplementation for cancer prevention in patients with
carcinoma of the skin. A randomized controlled trial. JAMA.
276:1957–1963. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Jablonska E and Vinceti M: Selenium and
Human Health: Witnessing a Copernican Revolution? J Environ Sci
Health C Environ Carcinog Ecotoxicol Rev. 33:328–368. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Higgins JP: A revised tool to assess risk
of bias in randomized trials. (RoB 2.0). 2016.
|
|
42
|
Rees K, Hartley L, Day C, Flowers N,
Clarke A and Stranges S: Selenium supplementation for the primary
prevention of cardiovascular disease. Cochrane Database Syst Rev.
1:CD0096712013.
|
|
43
|
Stratton MS, Reid ME, Schwartzberg G,
Minter FE, Monroe BK, Alberts DS, Marshall JR and Ahmann FR:
Selenium and prevention of prostate cancer in high-risk men: The
Negative Biopsy Study. Anticancer Drugs. 14:589–594. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Algotar AM, Stratton MS, Ahmann FR,
Ranger-Moore J, Nagle RB, Thompson PA, Slate E, Hsu CH, Dalkin BL,
Sindhwani P, et al: Phase 3 clinical trial investigating the effect
of selenium supplementation in men at high-risk for prostate
cancer. Prostate. 73:328–335. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Karp DD, Lee SJ, Keller SM, Wright GS,
Aisner S, Belinsky SA, Johnson DH, Johnston MR, Goodman G, Clamon
G, et al: Randomized, double-blind, placebo-controlled, phase III
chemoprevention trial of selenium supplementation in patients with
resected stage I non-small-cell lung cancer: ECOG 5597. J Clin
Oncol. 31:4179–4187. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Kristal AR, Darke AK, Morris JS, Tangen
CM, Goodman PJ, Thompson IM, Meyskens FL Jr, Goodman GE, Minasian
LM, Parnes HL, et al: Baseline selenium status and effects of
selenium and vitamin e supplementation on prostate cancer risk. J
Natl Cancer Inst. 106:djt4562014. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Albanes D, Till C, Klein EA, Goodman PJ,
Mondul AM, Weinstein SJ, Taylor PR, Parnes HL, Gaziano JM, Song X,
et al: Plasma tocopherols and risk of prostate cancer in the
Selenium and Vitamin E Cancer Prevention Trial (SELECT). Cancer
Prev Res (Phila). 7:886–895. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Martinez EE, Darke AK, Tangen CM, Goodman
PJ, Fowke JH, Klein EA and Abdulkadir SA: A functional variant in
NKX3.1 associated with prostate cancer risk in the Selenium and
Vitamin E Cancer Prevention Trial (SELECT). Cancer Prev Res
(Phila). 7:950–957. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Duffield-Lillico AJ, Slate EH, Reid ME,
Turnbull BW, Wilkins PA, Combs GF Jr, Park HK, Gross EG, Graham GF,
Stratton MS, et al: Nutritional Prevention of Cancer Study Group:
Selenium supplementation and secondary prevention of nonmelanoma
skin cancer in a randomized trial. J Natl Cancer Inst.
95:1477–1481. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Dréno B, Euvrard S, Frances C, Moyse D and
Nandeuil A: Effect of selenium intake on the prevention of
cutaneous epithelial lesions in organ transplant recipients. Eur J
Dermatol. 17:140–145. 2007.PubMed/NCBI
|
|
51
|
Lubinski J, Jaworska K, Durda K,
Jakubowska A, Huzarski T, Byrski T, Stawicka M, Gronwald J, Górski
B, Wasowicz W, et al: Selenium and the risk of cancer in BRCA1
carriers. Hered Cancer Clin Pract. 9:(Suppl 2). A52011. View Article : Google Scholar :
|
|
52
|
Duffield-Lillico AJ, Reid ME, Turnbull BW,
Combs GFJ Jr, Slate EH, Fischbach LA, Marshall JR and Clark LC:
Baseline characteristics and the effect of selenium supplementation
on cancer incidence in a randomized clinical trial: A summary
report of the Nutritional Prevention of Cancer Trial. Cancer
Epidemiol Biomarkers Prev. 11:630–639. 2002.PubMed/NCBI
|
|
53
|
Duffield-Lillico AJ, Dalkin BL, Reid ME,
Turnbull BW, Slate EH, Jacobs ET, Marshall JR and Clark LC:
Nutritional Prevention of Cancer Study Group: Selenium
supplementation, baseline plasma selenium status and incidence of
prostate cancer: An analysis of the complete treatment period of
the Nutritional Prevention of Cancer Trial. BJU Int. 91:608–612.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Vinceti M, Maraldi T, Bergomi M and
Malagoli C: Risk of chronic low-dose selenium overexposure in
humans: Insights from epidemiology and biochemistry. Rev Environ
Health. 24:231–248. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Yang GQ, Wang SZ, Zhou RH and Sun SZ:
Endemic selenium intoxication of humans in China. Am J Clin Nutr.
37:872–881. 1983.PubMed/NCBI
|
|
56
|
Barron E, Migeot V, Rabouan S,
Potin-Gautier M, Séby F, Hartemann P, Lévi Y and Legube B: The case
for re-evaluating the upper limit value for selenium in drinking
water in Europe. J Water Health. 7:630–641. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Frisbie SH, Mitchell EJ and Sarkar B:
Urgent need to reevaluate the latest World Health Organization
guidelines for toxic inorganic substances in drinking water.
Environ Health. 14:632015. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Scientific Committee on Food: Opinion of
the Scientific Committee on Food on the Tolerable Upper Intake
Level of SeleniumEuropean Commission. Brussels: 2000, https://ec.europa.eu/food/sites/food/files/safety/docs/sci-com_scf_out80g_en.pdf
|
|
59
|
Tsubota-Utsugi M, Imai E, Nakade M,
Tsuboyama-Kasaoka N, Morita A and Tokudome S: Dietary Reference
Intakes for Japanese - 2010. The summary report from the Scientific
Committee of ‘Dietary Reference intakes for Japanese’National
Institute of Health and Nutrition. Japan: 2012
|
|
60
|
Nordic Nutrition Recommendations 2012.
5th. Nordic Council of Ministers; Copenhagen: 2014, doi:
org/10.6027/Nord2014-002.
|
|
61
|
Società Italiana di Nutrizione Umana: LARN
- Livelli di assunzione di riferimento di nutrienti e energia per
la popolazione italiana - IV revisioneSICS. Milan: 2014, (In
Italian).
|
|
62
|
Marschall TA, Bornhorst J, Kuehnelt D and
Schwerdtle T: Differing cytotoxicity and bioavailability of
selenite, methylselenocysteine, selenomethionine, selenosugar 1 and
trimethylselenonium ion and their underlying metabolic
transformations in human cells. Mol Nutr Food Res. 60:2622–2632.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Lazard M, Dauplais M, Blanquet S and
Plateau P: Trans-sulfuration pathway seleno-amino acids are
mediators of selenomethionine toxicity in Saccharomyces cerevisiae.
J Biol Chem. 290:10741–10750. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Raine JC, Lallemand L, Pettem CM and Janz
DM: Effects of chronic dietary selenomethionine exposure on the
visual system of adult and F1 generation zebrafish (Danio rerio).
Bull Environ Contam Toxicol. 97:331–336. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Dolgova NV, Hackett MJ, MacDonald TC,
Nehzati S, James AK, Krone PH, George GN and Pickering IJ:
Distribution of selenium in zebrafish larvae after exposure to
organic and inorganic selenium forms. Metallomics. 8:305–312. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Göen T, Schaller B, Jäger T, Bräu-Dümler
Ch, Schaller KH and Drexler H: Biological monitoring of exposure
and effects in workers employed in a selenium-processing plant. Int
Arch Occup Environ Health. 88:623–630. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Jäger T, Drexler H and Göen T: Human
metabolism and renal excretion of selenium compounds after oral
ingestion of sodium selenate dependent on trimethylselenium ion
(TMSe) status. Arch Toxicol. 90:149–158. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Ito K, Mathes R, Ross Z, Nádas A, Thurston
G and Matte T: Fine particulate matter constituents associated with
cardiovascular hospitalizations and mortality in New York City.
Environ Health Perspect. 119:467–473. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Heck JE, Park AS, Qiu J, Cockburn M and
Ritz B: Risk of leukemia in relation to exposure to ambient air
toxics in pregnancy and early childhood. Int J Hyg Environ Health.
217:662–668. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Burk RF Jr: Selenium deficiency in search
of a disease. Hepatology. 8:421–423. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Yu FF, Liu H and Guo X: Integrative
multivariate logistic regression analysis of risk factors for
Kashin-Beck disease. Biol Trace Elem Res. 174:274–279. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Yu FF, Zhang YX, Zhang LH, Li WR, Guo X
and Lammi MJ: Identified molecular mechanism of interaction between
environmental risk factors and differential expression genes in
cartilage of Kashin-Beck disease. Medicine (Baltimore).
95:e56692016. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Beck MA, Levander OA and Handy J: Selenium
deficiency and viral infection. J Nutr. 133:(Suppl 1). 1463S–1467S.
2003.PubMed/NCBI
|
|
74
|
Sheridan PA, Zhong N, Carlson BA, Perella
CM, Hatfield DL and Beck MA: Decreased selenoprotein expression
alters the immune response during influenza virus infection in
mice. J Nutr. 137:1466–1471. 2007.PubMed/NCBI
|
|
75
|
Gu BQ: Pathology of Keshan disease. A
comprehensive review. Chin Med J (Engl). 96:251–261.
1983.PubMed/NCBI
|
|
76
|
Levander OA and Beck MA: Interacting
nutritional and infectious etiologies of Keshan disease. Insights
from coxsackie virus B-induced myocarditis in mice deficient in
selenium or vitamin E. Biol Trace Elem Res. 56:5–21. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Xu GL, Wang SC, Gu BQ, Yang YX, Song HB,
Xue WL, Liang WS and Zhang PY: Further investigation on the role of
selenium deficiency in the aetiology and pathogenesis of Keshan
disease. Biomed Environ Sci. 10:316–326. 1997.PubMed/NCBI
|
|
78
|
Chen J: An original discovery: Selenium
deficiency and Keshan disease (an endemic heart disease). Asia Pac
J Clin Nutr. 21:320–326. 2012.PubMed/NCBI
|
|
79
|
Guanqing H: On the etiology of Keshan
disease: Two hypotheses. Chin Med J (Engl). 92:416–422.
1979.PubMed/NCBI
|
|
80
|
Cermelli C, Vinceti M, Scaltriti E,
Bazzani E, Beretti F, Vivoli G and Portolani M: Selenite inhibition
of Coxsackie virus B5 replication: Implications on the etiology of
Keshan disease. J Trace Elem Med Biol. 16:41–46. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Schoenmakers E, Agostini M, Mitchell C,
Schoenmakers N, Papp L, Rajanayagam O, Padidela R, Ceron-Gutierrez
L, Doffinger R, Prevosto C, et al: Mutations in the selenocysteine
insertion sequence-binding protein 2 gene lead to a multisystem
selenoprotein deficiency disorder in humans. J Clin Invest.
120:4220–4235. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Scoto M, Cirak S, Mein R, Feng L, Manzur
AY, Robb S, Childs AM, Quinlivan RM, Roper H, Jones DH, et al:
SEPN1-related myopathies: Clinical course in a large cohort of
patients. Neurology. 76:2073–2078. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Ardissone A, Bragato C, Blasevich F,
Maccagnano E, Salerno F, Gandioli C, Morandi L, Mora M and Moroni
I: SEPN1-related myopathy in three patients: Novel mutations and
diagnostic clues. Eur J Pediatr. 175:1113–1118. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Schomburg L, Dumitrescu AM, Liao XH,
Bin-Abbas B, Hoeflich J, Köhrle J and Refetoff S: Selenium
supplementation fails to correct the selenoprotein synthesis defect
in subjects with SBP2 gene mutations. Thyroid. 19:277–281. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
85
|
EFSA NDA Panel: Scientific opinion on
dietary reference values for selenium. EFSA J. 12:38462014.
View Article : Google Scholar
|
|
86
|
Ge KY, Wang SQ, Bai J, Xue AN, Deng XJ, Su
CQ and Wu SQ: The protective effect of selenium against viral
myocarditis in miceSelenium in biology and medicine. Part B, Combs
GF, Spallholz JE, Levander OA and Oldfield JE: Avi Book, Van
Nostrand Reinhold Co.; New York: pp. 761–768. 1987
|
|
87
|
Spallholz JE: Free radical generation by
selenium compounds and their prooxidant toxicity. Biomed Environ
Sci. 10:260–270. 1997.PubMed/NCBI
|
|
88
|
Stewart MS, Spallholz JE, Neldner KH and
Pence BC: Selenium compounds have disparate abilities to impose
oxidative stress and induce apoptosis. Free Radic Biol Med.
26:42–48. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Letavayová L, Vlasáková D, Spallholz JE,
Brozmanová J and Chovanec M: Toxicity and mutagenicity of selenium
compounds in Saccharomyces cerevisiae. Mutat Res. 638:1–10. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Misra S, Boylan M, Selvam A, Spallholz JE
and Björnstedt M: Redox-active selenium compounds - from toxicity
and cell death to cancer treatment. Nutrients. 7:3536–3556. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Lee KH and Jeong D: Bimodal actions of
selenium essential for antioxidant and toxic pro-oxidant
activities: The selenium paradox (Review). Mol Med Rep. 5:299–304.
2012.PubMed/NCBI
|
|
92
|
Brozmanová J, Mániková D, Vlčková V and
Chovanec M: Selenium: A double-edged sword for defense and offence
in cancer. Arch Toxicol. 84:919–938. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Schiar VP, Dos Santos DB, Paixão MW,
Nogueira CW, Rocha JB and Zeni G: Human erythrocyte hemolysis
induced by selenium and tellurium compounds increased by GSH or
glucose: A possible involvement of reactive oxygen species. Chem
Biol Interact. 177:28–33. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Guo CH, Hsia S, Hsiung DY and Chen PC:
Supplementation with selenium yeast on the prooxidant-antioxidant
activities and anti-tumor effects in breast tumor xenograft-bearing
mice. J Nutr Biochem. 26:1568–1579. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Hafeman DG, Sunde RA and Hoekstra WG:
Effect of dietary selenium on erythrocyte and liver glutathione
peroxidase in the rat. J Nutr. 104:580–587. 1974.PubMed/NCBI
|
|
96
|
Oh SH, Sunde RA, Pope AL and Hoekstra WG:
Glutathione peroxidase response to selenium intake in lambs fed a
Torula yeast-based, artificial milk. J Anim Sci. 42:977–983. 1976.
View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Kramer GF and Ames BN: Mechanisms of
mutagenicity and toxicity of sodium selenite
(Na2SeO3) in Salmonella typhimurium. Mutat
Res. 201:169–180. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Macallan DC and Sedgwick P: Selenium
supplementation and selenoenzyme activity. Clin Sci (Lond).
99:579–581. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Tsongas TA and Ferguson SW: Selenium
concentrations in human urine and drinking waterProceedings of
‘Trace Elements in Man and Animal-3’. Kirchgessner N: Institute for
Nursing Physiology Technical University Munchen; Freising: pp.
320–321. 1978
|
|
100
|
Tsongas TA and Ferguson SW: Human health
effects of selenium in a rural Colorado drinking water supply. In:
Proceedings of ‘Trace substances in environmental health-XIA
symposium’. Hemphill DD: University of Missouri; Columbia: pp.
30–35. 1977
|
|
101
|
Valentine JL: Environmental occurrence of
selenium in waters and related health significance. Biomed Environ
Sci. 10:292–299. 1997.PubMed/NCBI
|
|
102
|
Valentine JL, Kang HK, Dang PM and
Schluchter M: Selenium concentrations and glutathione peroxidase
activities in a population exposed to selenium via drinking water.
J Toxicol Environ Health. 6:731–736. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Valentine JL, Faraji B and Kang HK: Human
glutathione peroxidase activity in cases of high selenium
exposures. Environ Res. 45:16–27. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Valentine JL, Reisbord LS, Kang HK and
Schluchter M: Effects on human health of exposure to selenium in
drinking waterProceedings of ‘Selenium in Biology and Medicine -
Part B’. Combs GF, Levander OA, Spallholz JE and Oldfield JE: Van
Nostrand Reihold Co.; New York: pp. 675–687. 1987
|
|
105
|
Longnecker MP, Taylor PR, Levander OA,
Howe M, Veillon C, McAdam PA, Patterson KY, Holden JM, Stampfer MJ,
Morris JS, et al: Selenium in diet, blood, and toenails in relation
to human health in a seleniferous area. Am J Clin Nutr.
53:1288–1294. 1991.PubMed/NCBI
|
|
106
|
Brätter P and de Negretti Brätter VE:
Influence of high dietary selenium intake on the thyroid hormone
level in human serum. J Trace Elem Med Biol. 10:163–166. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Fordyce FM, Zhan G, Green K and Liu X:
Soil, grain and water chemistry in relation to human
selenium-responsive diseases in Enshi District, China. Applied
Geochemistry. 15:117–132. 2000.doi: 10.1016/S0883-2927(99)00035-9.
View Article : Google Scholar
|
|
108
|
Zhu J, Wang N, Li S, Li L, Su H and Liu C:
Distribution and transport of selenium in Yutangba, China: Impact
of human activities. Sci Total Environ. 392:252–261. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Hira CK, Partal K and Dhillon KS: Dietary
selenium intake by men and women in high and low selenium areas of
Punjab. Public Health Nutr. 7:39–43. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Lemire M, Fillion M, Frenette B, Passos
CJ, Guimarães JR, Barbosa F Jr and Mergler D: Selenium from dietary
sources and motor functions in the Brazilian Amazon.
Neurotoxicology. 32:944–953. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Lemire M, Philibert A, Fillion M, Passos
CJ, Guimarães JR, Barbosa F Jr and Mergler D: No evidence of
selenosis from a selenium-rich diet in the Brazilian Amazon.
Environ Int. 40:128–136. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Qin HB, Zhu JM, Liang L, Wang MS and Su H:
The bioavailability of selenium and risk assessment for human
selenium poisoning in high-Se areas, China. Environ Int. 52:66–74.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Martens IB, Cardoso BR, Hare DJ,
Niedzwiecki MM, Lajolo FM, Martens A and Cozzolino SM: Selenium
status in preschool children receiving a Brazil nut-enriched diet.
Nutrition. 31:1339–1343. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Chawla R, Loomba R, Chaudhary RJ, Singh S
and Dhillon KS: Impact of high selenium exposure on organ function
and biochemical profile of the rural population living in
seleniferous soils in Punjab, IndiaGlobal advance in selenium
research from theory to application. CRC Press; Sao Paulo: pp.
93–94. 2015, View Article : Google Scholar
|
|
115
|
Yu SY, Zhu YJ and Li WG: Protective role
of selenium against hepatitis B virus and primary liver cancer in
Qidong. Biol Trace Elem Res. 56:117–124. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Yu SY, Zhu YJ, Li WG, Huang QS, Huang CZ,
Zhang QN and Hou C: A preliminary report on the intervention trials
of primary liver cancer in high-risk populations with nutritional
supplementation of selenium in China. Biol Trace Elem Res.
29:289–294. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Li WG: Preliminary observations on effect
of selenium yeast on high risk populations with primary liver
cancer. Zhonghua Yu Fang Yi Xue Za Zhi. 26:268–271. 1992.(In
Chinese). PubMed/NCBI
|
|
118
|
Li W, Zhu Y, Yan X, Zhang Q, Li X, Ni Z,
Shen Z, Yao H and Zhu J: The prevention of primary liver cancer by
selenium in high risk populations. Zhonghua Yu Fang Yi Xue Za Zhi.
34:336–338. 2000.(In Chinese). PubMed/NCBI
|
|
119
|
Lotan Y, Goodman PJ, Youssef RF, Svatek
RS, Shariat SF, Tangen CM, Thompson IM Jr and Klein EA: Evaluation
of vitamin E and selenium supplementation for the prevention of
bladder cancer in SWOG coordinated SELECT. J Urol. 187:2005–2010.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Klein EA, Thompson IM Jr, Tangen CM,
Crowley JJ, Lucia MS, Goodman PJ, Minasian LM, Ford LG, Parnes HL,
Gaziano JM, et al: Vitamin E and the risk of prostate cancer: The
Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA.
306:1549–1556. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Marshall JR, Tangen CM, Sakr WA, Wood DP
Jr, Berry DL, Klein EA, Lippman SM, Parnes HL, Alberts DS, Jarrard
DF, et al: Phase III trial of selenium to prevent prostate cancer
in men with high-grade prostatic intraepithelial neoplasia: SWOG
S9917. Cancer Prev Res (Phila). 4:1761–1769. 2011. View Article : Google Scholar : PubMed/NCBI
|
